From American Diabetes Association <[email protected]>
Subject Join the fight: Support diabetes research and save lives
Date July 23, 2024 10:32 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Your donation fuels critical research that impacts diabetes prevention
and care.

American Diabetes Association Logo

 

 

Research Is Key?in the Fight to End Diabetes

"As a first timer, I've got to say that the ADA's Scientific
Sessions is impressive. I realized that THIS is the fight. THIS is
where the fight will be won. Lives will be changed, and all of us will
end diabetes together." -Molly Butz, the ADA's Web Lifestyle
Content Manager and living with T1 diabetes

Donate Now

[link removed]

Your donation can help advance diabetes research and care! 

Friend,

We've officially wrapped up this year's 84th Scientific
Sessions of the American Diabetes Association® (ADA), the
world's largest meeting on diabetes research, prevention, and
care. 

The 84th Scientific Sessions provided a fresh outlook on the
lifesaving research that will improve the lives of millions living
with diabetes-and so will your donation!

The Scientific Sessions unveiled cutting-edge research such as:

* Weight-loss drug reduces kidney disease risk by 24% Findings
from a new trial showed that semaglutide (a weight-loss
medication) significantly reduces the risk of major kidney
disease events and cardiovascular causes in people with type 2
diabetes and chronic kidney disease (CKD).
* Breakthrough studies on AID and CGM New data revealed that
technology such as automated insulin delivery (AID) systems and
continuous glucose monitoring (CGM) improve blood glucose (blood
sugar) levels and overall diabetes management.
*

Innovations in medications for people with obesity

In addition to helping people with obesity reach a healthy
weight, findings from  these studies showed that
weight-loss medications also improve blood glucose and blood
pressure management and reduce cholesterol levels while
preserving lean mass (which mostly includes muscle)

*

Weight-loss drug shown to improve sleep apnea and CVD

Findings from a study discovered that people with sleep apnea
and obesity who took tirzepatide (a weight-loss medication)
significantly improved their sleep apnea, lost weight, and
reduced their risk for cardiovascular disease (CVD).

This premier gathering of some of the world's brightest minds
and experts on diabetes research and treatment brings groundbreaking
innovations from the lab to everyday care. This critical work is
pivotal in diabetes prevention and management-and so is your
support! 

Support Research

[link removed]

A donation from you today may support lifesaving diabetes treatments,
fuels research to reduce severe complications from diabetes, and funds
critical research to find a cure. 

Friend, you can support the fight to end diabetes once and
for all alongside ADA researchers to make a difference in the lives of
the 136 million Americans living with diabetes or prediabetes with
your donation. Will you stand with us in the fight? 

Stand with Us

[link removed]

 

Donate Monthly

[link removed]

Donate Once

[link removed]

 

Ways to Give:  Monthly  |  Once  |  Stock

[link removed]

[link removed]

[link removed]

Employer Match  | Donate Your Car

[link removed]

[link removed]

 




























 

Facebook

[link removed]

Twitter

[link removed]

Instagram

[link removed]

Linkedin

[link removed]

YouTube

[link removed]

© American Diabetes Association. All rights reserved.

[email protected] | 1-800-342-2383

Learn more at diabetes.org
[link removed]

Forward to a Friend | Manage Your Communication | Unsubscribe
[link removed]

[link removed]
[link removed]
Screenshot of the email generated on import

Message Analysis